Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

Autogenerated by for
Created on Wed, 2020-10-14 09:49, last updated on Wed, 2020-10-14 09:49

Vertical Tabs

QR Code for https://3dprint.nih.gov/discover/3dpx-014937

Rating

No votes yet

Licensing

Comments